Clinical Trials Directory

Trials / Unknown

UnknownNCT05539898

Improving the Criteria for Selecting Patients for Primary Prevention of Sudden Cardiac Death by Arrhythmic Risk Stratification

Improving the Criteria for Selecting Patients for Primary Prevention of Sudden Cardiac Death by Stratification of the Risk of Stable Ventricular Tachyarrhythmias

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
450 (estimated)
Sponsor
Astrakhan Federal Centre For Cardiac Surgery · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

A number of large randomized studies have demonstrated the importance of left ventricle ejection fraction (LV EF) for ventrucular tachyarhrythmia's (VT) prediction. The use of this indicator as the sole predictor of high arrhythmic risk requiring ICD implantation is enshrined in the current clinical recommendations. At the same time, many experts consider LV EF as too generalized indicator, which can be an integral indicator of total cardiovascular mortality, but lacks specificity in determining the risk of VT. It is known that only about 20% of patients with ICD implanted for primary prevention of sudden cardiac death (SCD) receive appropriate life-saving therapy. Purpose of the study: to develop additional criteria for selection of patients with heart failure for implantation of cardioverter-defibrillator for the purpose of primary SCD prevention on the basis of stratification of the risk of occurrence of stable ventricular tachyarrhythmias.

Conditions

Interventions

TypeNameDescription
DEVICEICD implantationAll included in the study will undergo ICD implantation for primary prevention of SCD

Timeline

Start date
2017-01-13
Primary completion
2023-12-29
Completion
2024-12-29
First posted
2022-09-14
Last updated
2023-02-01

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT05539898. Inclusion in this directory is not an endorsement.